No Data
LEAP Awarded "Overall Practice Management Solution of the Year" Again by LegalTech Breakthrough
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Buy Recommendation for Leap Therapeutics: Promising Phase 2 Trial Developments and Stable Financial Outlook
Leap Therapeutics | 8-K: Leap Therapeutics Reports Third Quarter 2024 Financial Results
Express News | Leap Therapeutics Q2 2024 GAAP EPS $(0.52) Misses $(0.43) Estimate
Leap Therapeutics: Cash Position Expected to Fund Operations Into 2Q 2026 >LPTX